![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 36, 26562-26568, September 8, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||










1
From the
Ludwig Institute for Cancer Research, San Diego Branch,
Biomedical Sciences Graduate Program, 
Center for Molecular Genetics, 
Department of Medicine and Cancer Center, University of California at San Diego, La Jolla, California 92093-0660, the ¶Departments of Neurology and Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9133, and the ||Department of Medical Oncology and **Departments of Genetics and Medicine, Harvard Medical School, Boston, Massachusetts 02115
The PTEN protein has a single catalytic domain possessing both lipid phosphoinositol and protein phosphatase activities. The lipid phosphoinositol phosphatase activity is essential for PTEN to block the cell cycle in the G1 phase and thereby to suppress tumor formation and progression (Cantley, L. C., and Neel, B. G. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4240-4245), although the mechanisms governing PTEN activity under normal and neoplastic growth conditions remain unclear. Here, we report that PTEN interacts physically and functionally with PCAF, a histone acetyltransferase that regulates gene transcription through interaction with p300/CBP and various sequencespecific transcription factors (Nakatani, Y. (2001) Genes Cells 6, 79-86). Expression of PCAF results in increased acetylation of lysine residues (Lys125 and Lys128) within the catalytic cleft of PTEN, a structure essential for phosphatidylinositol 3,4,5-trisphosphate specificity (Lee, J. O., Yang, H., Georgescu, M. M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., and Pavletich, N. P. (1999) Cell 99, 323-334). The acetylation of PTEN caused by PCAF expression depends on the presence of growth factors. Reduction of endogenous PCAF activity using shRNA results in a loss of PTEN acetylation in response to growth factors and restores the ability of PTEN to down-regulate phosphatidylinositol 3-kinase signaling and to induce G1 cell cycle arrest. The retention of phosphatidylinositol 3-kinase/AKT signaling and cell cycle regulatory activities of acetylationresistant PTEN K125R and K128R mutants in the presence of enforced PCAF expression suggest a causal relationship. Together, these findings indicate a mechanism of PTEN regulation that forges a link between distinct cancer-relevant pathways central to the control of growth factor signaling and gene expression.
Received for publication, June 5, 2006 , and in revised form, July 6, 2006.
* This work was supported in part by Scholar Awards for cancer research from the Kimmel Foundation and the V Foundation (to F. B. F.), Grant CA95616 from the National Cancer Institute (to W. K. C., R. M. B., F. B. F., and R. A. D.), and by a Fellow Award from the National Foundation for Cancer Research (to W. K. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
This article was selected as a Paper of the Week.
1 To whom correspondence should be addressed. Tel.: 858-534-7819; Fax: 858-534-7750; E-mail: ffurnari{at}ucsd.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. Ikenoue, K. Inoki, B. Zhao, and K.-L. Guan PTEN Acetylation Modulates Its Interaction with PDZ Domain Cancer Res., September 1, 2008; 68(17): 6908 - 6912. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roy, R. Jeffrey, and M. Tenniswood Array-based analysis of the effects of trichostatin A and CG-1521 on cell cycle and cell death in LNCaP prostate cancer cells Mol. Cancer Ther., July 1, 2008; 7(7): 1931 - 1939. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Yao and B. L. G. Nyomba Hepatic insulin resistance induced by prenatal alcohol exposure is associated with reduced PTEN and TRB3 acetylation in adult rat offspring Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1797 - R1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dey, H. E. Crosswell, P. De, R. Parsons, Q. Peng, J. D. Su, and D. L. Durden The Protein Phosphatase Activity of PTEN Regulates Src Family Kinases and Controls Glioma Migration Cancer Res., March 15, 2008; 68(6): 1862 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tamguney and D. Stokoe New insights into PTEN J. Cell Sci., December 1, 2007; 120(23): 4071 - 4079. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Eliseeva, V. Valkov, M. Jung, and M. O. Jung Characterization of novel inhibitors of histone acetyltransferases Mol. Cancer Ther., September 1, 2007; 6(9): 2391 - 2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roy and M. Tenniswood Site-specific Acetylation of p53 Directs Selective Transcription Complex Assembly J. Biol. Chem., February 16, 2007; 282(7): 4765 - 4771. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Barber, M. Alvarado-Kristensson, A. Gonzalez-Garcia, R. Pulido, and A. C. Carrera PTEN Regulation, a Novel Function for the p85 Subunit of Phosphoinositide 3-Kinase Sci. Signal., November 21, 2006; 2006(362): pe49 - pe49. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |